Navigation Links
The Hepatitis C Virus Drug Market Will Nearly Triple by 2014 but, Thereafter, the Market Will Decline Substantially Through 2019 Due to Decreasing Disease Prevalence and the High Efficacy of New Treatments
Date:11/16/2010

BURLINGTON, Mass., Nov. 16, 2010 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that, owing to the launch of several novel agents, the hepatitis C virus (HCV) drug market will more than triple from approximately $2 billion in 2009 to nearly $7.5 billion in 2014 in the United States, France, Germany, Italy, Spain, the United Kingdom and Japan. Thereafter, the market will substantially decrease to $4.6 billion in 2019 due to decreasing prevalence of the disease and the high efficacy of new treatment regimens.

The Pharmacor 2010 findings from the topic entitled Hepatitis C Virus reveal that the standard of care for the indication will change significantly with the introduction of new classes of HCV-specific antiviral agents, such as protease inhibitors and polymerase inhibitors. Compounds from these new classes will initially be added to the backbone of currently used agents, forming triple or quadruple treatment regimens that are expected to be more efficacious than the current standard of care -- peg-IFN/ribavirin.

"Although complete elimination of peg-IFNs and ribavirin agents is highly desirable owing to their side effects, this change is unlikely to occur over the next decade," said Decision Resources Analyst Alexandra Makarova, M.D., Ph.D. "However, decreased treatment durations resulting from the addition of new antivirals could increase the tolerability of treatment regimens. The launch of novel HCV-specific agents will increase the size of the drug-treated population, owing mainly to re-treatment of prior non-responders as well as increased referral and drug-treatment rates."

The current standard of care for HCV -- often a nearly year-long treatment -- cures only about half of patients and is associated with severe side effects. Although the incidence of HCV has declined dramatically after the introduction of prevention measures such as b
'/>"/>

SOURCE Decision Resources
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Abbott and Enanta Present Positive Initial Results from Phase 2 Study of ABT-450/r for Treatment of Hepatitis C
2. AASLD Presidents Choice Lecture: The National Strategy for the Control of Viral Hepatitis and Liver Cancer
3. Telbivudine Given to Mothers With Hepatitis B Reduces Infection Rate in Infants
4. Achieving Sustained Viral Response for Patients with Recurrent Hepatitis C After Transplantation is Key for Long-Term Outcomes
5. Results of Boehringer Ingelheim Oral Hepatitis C Protease Inhibitor and Polymerase Inhibitor Combination Phase Ib Trial Shows Rapid Viral Response Without Use of Pegylated Interferon
6. Roche Receives FDA Approval for a Second-Generation Hepatitis C Viral Load Test
7. Romark and Intercell Join Forces in Combining Therapies Against Hepatitis C
8. Intercell and Romark Join Forces in Combining Therapies Against Hepatitis C
9. Millions of Americans Are Living With Hidden Epidemics of Hepatitis B and C, Top Experts Warn
10. Launch of Novel Agents for the Treatment of Hepatitis C Virus Will Precipitate Treatment of At Least Half of Warehoused Patients
11. Roche Receives FDA Approval for Second-Generation Hepatitis B Viral Load Test
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/3/2015)... Men with benign prostatic hyperplasia (BPH), ... but not cancerous, have a new, breakthrough treatment ... complications than other minimally invasive treatments, such as ... according to research presented at the Society ... Meeting . Using an interventional radiology treatment known ...
(Date:3/3/2015)... -- Although lung cancer is the third most prevalent ... drugs in the market for its treatment. Further, popular ... patent expiry in 2015 and 2017 respectively. As such, ... drug manufacturers are vying to tap into. Approximately 130 ... (SCLC) and non-small cell lung cancer (NSCLC) are in ...
(Date:3/3/2015)... Chrono Therapeutics , a pioneer in ... Rock Health , the leading seed fund in digital ... transdermal drug delivery system and real-time behavioral support program ... than 500,000 Americans each year, and is responsible for ... United States . Of the 45 million smokers ...
Breaking Medicine Technology:Interventional radiology offers new treatment for enlarged prostates 2Interventional radiology offers new treatment for enlarged prostates 3Interventional radiology offers new treatment for enlarged prostates 4Targeted Lung Cancer Therapies Are Supplanting Conventional Treatments 2Targeted Lung Cancer Therapies Are Supplanting Conventional Treatments 3Chrono Therapeutics Receives Investment from Rock Health to Advance SmartStopTM Smoking Cessation Technology 2Chrono Therapeutics Receives Investment from Rock Health to Advance SmartStopTM Smoking Cessation Technology 3
... Reportlinker.com announces that a new market research ... Top Medical Devices and Imaging ... This research service discusses ... have excellent growth potential in the next ...
... , Pharma IQ has just published ... recently among 3,000,pharmaceutical distribution specialist with over 83 ... their respective,companies. The results showed that ... current level of service they received from,external partners ...
Cached Medicine Technology:Reportlinker Adds Top Medical Devices and Imaging Technologies 2011 2Pharma IQ's Pharma Distribution Survey report 2Pharma IQ's Pharma Distribution Survey report 3
(Date:3/3/2015)... Dr. Stephen Edgerton, a Cosmetic ... achieved Accredited Member Status in the American Academy ... accomplishment after completing a rigorous credentialing process including ... submission of clinical cases for examination. , ... in Connecticut, Charlotte, North Carolina, Caracas, Venezuela and ...
(Date:3/3/2015)... California (PRWEB) March 03, 2015 ... effect entitled inMotion3D Environment from Pixel Film Studios. , ... 2D HDRI image into 360° viewing area inside Motion ... “inMotion3D Environment blurs the line between professional and amateur ... 5 users can turn their 2D HDRI images into ...
(Date:3/3/2015)... Aureus Medical Group (web: aureuslocumtenens.com), a national ... that it will participate as an exhibitor at the ... 2015 in St. Louis, MO. , CareerMD Career Fairs ... and fellows in a comfortable, relaxed setting. , Representatives ... available to speak with attendees about its full range ...
(Date:3/3/2015)... Motion Graphics artist at ... new plugin FCPX3D Confetti designed exclusively for Final Cut ... using confetti particles inside FCPX,” said Christina Austin, CEO ... transition, users will have fun as they choose, drag, ... clip to the next with 3D tumbling or exploding ...
(Date:3/2/2015)... March 02, 2015 Formetco today announced ... design. The FTX uses state-of-the-art technology to deliver ... reliability, and owner satisfaction. An item of particular ... exclusive Formetco 10 year LED Brightness Warranty. , Why ... be a superior billboard among any other billboard product ...
Breaking Medicine News(10 mins):Health News:Dr. Edgerton, a Dentist in Wilmington, NC, Achieves Accredited Status in AACD 2Health News:A New Plugin Entitled inMotion3D Environment Was Released Today from Pixel Film Studios Exclusively for Motion 5 2Health News:A new Confetti Generator entitled FCPX3D Confetti was released today from Pixel Film Studios for Final Cut Pro X 2Health News:Formetco Launches Innovative LED Billboard System 2
... Nevique(TM), a newly,founded skin care company based ... Omega 3 skin care technology at the upcoming,ECRM/EPPS ... August 5-8, 2008. The,Nevique(TM) skin care line initially ... 1) Ultra Moisturizer, 2) Daily Conditioner, 3) Medicated,Mint, ...
... Delegation of the Commission will dialogue with leaders at,the ... response,to the HIV/AIDS pandemic, NEW YORK, July 30 ... affected community, it is estimated that more,than 200,000 individuals ... has reached a crisis level. Representing only 15.3% of,the ...
... manage consumers. , ... Orlando, FL (Vocus) July 31, ... Applications vendor in its "Hype Cycle for Healthcare Payers, 2008" report. ... to attract, retain and manage individual and small group ...
... MILLS, Md., July 31 Medifast, Inc.,(NYSE: ... published in ,The Journal,of Eating and Weight Disorders, ... double the weight loss when they combine,their drug ... Replacement,Supplements., The 52-week study, conducted by researchers ...
... http://www.publicintegrity.org/investigations/pesticides , Center Unveils New Report Based ... According to a new,Center for Public Integrity ... pyrethrins and,pyrethroids were responsible for more than 26 ... pesticides in the United States in 2007,up from ...
... in Kansas City Area, MERRIMACK, N.H., July ... shaping, Eleme Medical Inc. announced today that Gary ... plastic surgeon to offer the,SmoothShapes(R) system for longer-lasting ... Summit and Northland Kansas City. Rajeunir,is hosting a ...
Cached Medicine News:Health News:Nevique Skin Care Company Introducing the Revolutionary New Omega 3 Skin Care Technology 2Health News:The Latino Commission on AIDS Releases Report on the State of HIV/AIDS in Latino/Hispanic Communities in the United States on the Eve of the International AIDS Conference in Mexico City 2Health News:Connextions Cited in Leading Industry Analyst Firm's "Hype Cycle" For Health Care Provider Marketing Applications 2Health News:Connextions Cited in Leading Industry Analyst Firm's "Hype Cycle" For Health Care Provider Marketing Applications 3Health News:Medifast Program Combined with Appetite Suppressants Proven to Yield Double the Weight Loss Compared to Suppressants Alone 2Health News:'Safe' Pesticides Now First in Poisonings 2Health News:'Safe' Pesticides Now First in Poisonings 3Health News:New Anti-Cellulite Treatment Prepares Women for Warmer Weather and Beyond 2Health News:New Anti-Cellulite Treatment Prepares Women for Warmer Weather and Beyond 3
... Our most popular onsite test! QuickScreen multi-panel ... urine sample, and your choice of any ... multi-panels offer total flexibility for your drug ... the specimen and the built-in timer tells ...
... The SureStep™ Drug Screen Tests are available ... for MDMA (Ecstasy). Designed using Microgenics Antibody ... the only point of care immunoassay targeted ... for both MDA and MDEA but no ...
Accu-Stat Home Drug Test for Marijuana (THC), Cocaine (COC), Amphetamine (AMP), Methamphetamine (mAMP), Opiates (OPI), and Phencyclidine (PCP)....
... drugs of abuse tests are highly accurate in ... recommended cut-off as confirmed by GC/MS testing. This ... specific alternative method (such as GC/MS) must be ... Professional judgment should be applied to any drug ...
Medicine Products: